Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo-control randomized trial

Lamina, Sikiru; Shmaila, Hanif; Muhammed, Samani A

doi:10.1590/s1677-55382008000600005

Cited by 45 publications

(17 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several prospective studies have implicated TENS as an effective and safe treatment warranting randomized, placebo, controlled trials. [1213141516]…”

Section: Discussionmentioning

confidence: 99%

Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain

2017

View full text Add to dashboard Cite

Background:Chronic pelvic pain is prevalent in 2% of women population globally. The etiology is multifactorial. Even in the absence of pelvic pathology, there is a subgroup of women who do not respond to analgesic and anti-inflammatory therapy. Chronic pelvic pain can be inhibited by direct inhibition of impulses in the preganglionic afferent neuron by closing the hypothetical gate in the dorsal horn of the spinal cord. Transcutaneous electrical nerve stimulation (TENS) is based on the gate control theory of abolishing the painful stimuli by providing simultaneous inputs in larger myelinated nerve fibers.Aims and Objectives:This study was designed to assess the effectiveness and safety of TENS in idiopathic chronic pelvic pain.Methods:It is a prospective, experimental study to evaluate the effectiveness of TENS versus placebo in reducing pain severity in chronic pelvic pain (G1 = 30, G2 = 32, G3 = 30, and G0 = 30). Patients with chronic pelvic pain due to benign lesions of genital tract, gastrointestinal, and renal disorders were excluded from the study after performing an ultrasound study of abdomen and pelvis. Ten treatment sessions (5 sessions/week) of 30 min were conducted.Observations and Results:There was a significant improvement in pain scores in TENS group as compared with control group, and two patients were completely pain free following TENS therapy.Conclusion:In women patients with idiopathic chronic pelvic pain, TENS can be a useful intervention. TENS units are safe, economical, and easily commercially available.

show abstract

“…Several prospective studies have implicated TENS as an effective and safe treatment warranting randomized, placebo, controlled trials. [1213141516]…”

Section: Discussionmentioning

confidence: 99%

Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain

2017

View full text Add to dashboard Cite

show abstract

“… 8 , 29 Also, a similar pain reduction effect of TENS was noted for chronic prostatitis and chronic pelvic pain. 12 , 30 …”

Section: Discussionmentioning

confidence: 99%

“… 1 , 5 , 7 There are many physical therapy modalities to relieve and control ICO-associated pain, such as transcutaneous electrical nerve stimulation (TENS), interferential (IF) therapy, pelvic floor muscle training, and radiofrequency treatment. 12 – 15 …”

Section: Introductionmentioning

confidence: 99%

Does transcutaneous electrical nerve stimulation reduce pain and improve quality of life in patients with idiopathic chronic orchialgia? A randomized controlled trial

Tantawy

Kamel

Abdelbasset

2017

JPR

View full text Add to dashboard Cite

BackgroundChronic orchialgia is defined as testicular pain, which may be either unilateral or bilateral, lasting for more than 3 months. It disturbs a patient’s daily activities and quality of life (QoL), inciting the patient to search for treatments to alleviate the pain. It is estimated that 25% of chronic orchialgia cases are idiopathic.PurposeThe purpose of this study was to investigate how effective transcutaneous electrical nerve stimulation (TENS) is in pain reduction and how it consequently affects the QoL in patients with idiopathic chronic orchialgia (ICO).Patients and methodsSeventy-one patients were randomly assigned to group A (study group), which included 36 patients who received TENS and analgesia, and group B (control group), which included 35 patients who received analgesia only. The outcome measures were the participants’ demographic data and results of the visual analog scale (VAS) and QoL questionnaire. These outcomes were measured before and after 4 weeks of treatment and at 2-month follow-up.ResultsThe results showed that compared to pretreatment, there was a significant reduction in pain postintervention and at 2-month follow-up in group A (P<0.0001 and <0.001, respectively; F=7.1) as well as a significant improvement in QoL at these time points (P<0.0001 and <0.0001, respectively). There were no significant differences in the VAS score and QoL in group B at different time points of evaluation.ConclusionThe findings indicate that TENS is effective in reducing pain and improving patients’ QoL in cases of ICO. TENS is an easy-to-use, effective, noninvasive, and simple method for ICO-associated pain control and QoL improvement.

show abstract

“…-Transcutaneous electrical nerve stimulation (TENS) stimulates certain nerve fibers to block pain transmission at the central level. (56) -Pulsed radiofrequency.…”

Section: Non-pharmacologic Treatment Optionsmentioning

confidence: 99%

Etiology of testicular pain 2019: Classification into ten logical subgroups

Arcila

Delgado-Montoya

Gaviria-Gil

2020

rmu

View full text Add to dashboard Cite

Background: Testicular pain encompasses a vast medical diagnostic field, with numerous organ and system convergence. Acute testicular pain is a medical emergency that requires accurate evaluation and immediate resolution, whereas chronic testicular pain is enigmatic and requires sound knowledge of the mechanisms of testicular pain and the differential diagnosis. Objective: To review the causes of testicular pain and propose a new etiologic classification consisting of 10 subgroups. Methods: A bibliographic search was carried out utilizing Google and the National Library of Medicine’s PubMed databases to identify original articles and review articles (hard copy or electronic) published on testicular pain, up to March 2020. The search included: MeSH terms: testicular disease (classification, complications, etiology, trauma, microbiology, pathology, pathophysiology, secondary, surgery, treatment) and vasectomy; Non-MeSH terms: acute and chronic orchialgia, scrotalgia, orchidynia, groin pain, epididymalgia, testalgia, chronic testicular pain, chronic scrotal pain syndrome, testicular pain syndrome, epididymal pain syndrome, and post-vasectomy pain syndrome. The initial search produced 625 articles, of which 143 were included in the present review. Results: To better understand testicular pain etiology, 100 possible diagnoses were divided into ten subgroups: infectious, neoplastic, traumatic, torsional, vascular, immunologic, neurologic, pharmacologic, obstructive, and miscellaneous causes. Likewise, treatment can be divided into two main groups, according to therapeutic options: pharmacologic and non-pharmacologic, with the latter subdivided into: noninvasive and the increasingly performed invasive (surgical) alternatives. Conclusions: Testicular pain should be understood as a complex pain syndrome of enigmatic origin. Treatment success depends on the correct identification, from hundreds of possibilities, of the cause of pain. Logical grouping of those possibilities could aid in making the accurate etiologic identification.

show abstract

Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo-control randomized trial

Cited by 45 publications

References 23 publications

Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain

Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain

Does transcutaneous electrical nerve stimulation reduce pain and improve quality of life in patients with idiopathic chronic orchialgia? A randomized controlled trial

Etiology of testicular pain 2019: Classification into ten logical subgroups

Contact Info

Product

Resources

About